PB2349: LESSONS LEARNED FROM THE MYPAL DIGITAL HEALTH INTERVENTION: CAPITALIZING ON THE PATIENT REPORTED OUTCOMES (PRO) PARADIGM TOWARDS A PARTICIPATORY HEALTHCARE FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

PB2349: LESSONS LEARNED FROM THE MYPAL DIGITAL HEALTH INTERVENTION: CAPITALIZING ON THE PATIENT REPORTED OUTCOMES (PRO) PARADIGM TOWARDS A PARTICIPATORY HEALTHCARE FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

Bibliographic Details
Main Authors:	C. Karamanidou, L. Scarfò, M. Doubek, S. Garani-Papadatos, J. Didi, C. Pontikoglou, E. Kazantzaki, J. Ling, C. Pain, H. Papadaki, R. Rosenquist, N. Stavroyianni, S. Payne, P. Ghia, K. Stamatopoulos, P. Natsiavas
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000852220.94026.95

Similar Items

Ethical Principles in Digital Palliative Care for Children: The MyPal Project and Experiences Made in Designing a Trustworthy Approach
by: Tina Garani-Papadatos, et al.
Published: (2022-03-01)

Assessing Patients’ Knowledge on Chronic Lymphocytic Leukemia: Validation of the ERIC CLL Knowledge Questionnaire in Greece
by: Christina Karamanidou, et al.
Published: (2021-03-01)

2349
by: Rowland Han, et al.
Published: (2017-09-01)

PB2362: BEST PRACTICES ON EMPOWERING AND INVOLVING PATIENTS LIVING WITH HEMATOLOGICAL MALIGNANCIES ON THE DEVELOPMENT OF NOVEL PATIENT-REPORTED OUTCOME MEASURES
by: N. Vrontaras, et al.
Published: (2022-06-01)

How do Hematologists Communicate with Patients Suffering from Chronic Lymphocytic Leukemia?
by: Christina Karamanidou, et al.
Published: (2021-12-01)

Fostering Palliative Care Through Digital Intervention: A Platform for Adult Patients With Hematologic Malignancies
by: Lefteris Koumakis, et al.
Published: (2021-12-01)

2349 The role of interleukin-23 in human melanoma
by: Aditi Jani, et al.
Published: (2018-06-01)

Electrocardiographic Effects of a Supratherapeutic Dose of WCK 2349, a Benzoquinolizine Fluoroquinolone
by: Jay W. Mason, et al.
Published: (2019-01-01)

T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations
by: Elisavet Vlachonikola, et al.
Published: (2023-02-01)

8-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one
by: R. Archana, et al.
Published: (2010-09-01)

6-Methyl-2,3,4,9-tetrahydro-1H-carbazole-1-thione
by: R. Archana, et al.
Published: (2011-07-01)

2-(6-Chloro-2,3,4,9-tetrahydro-1H-carbazol-1-ylidene)propanedinitrile
by: M. Sekar, et al.
Published: (2011-12-01)

The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting
by: Charalampos G. Pontikoglou, et al.
Published: (2023-01-01)

6-Bromo-2-(3-phenylallylidene)-2,3,4,9-tetrahydro-1H-carbazol-1-one
by: R. Velmurugan, et al.
Published: (2011-12-01)

EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia
by: Subazini Thankaswamy Kosalai, et al.
Published: (2019-11-01)

Brightest Cluster Galaxy Formation in the z = 4.3 Protocluster SPT 2349-56: Discovery of a Radio-loud Active Galactic Nucleus
by: Scott C. Chapman, et al.
Published: (2024-01-01)

(E)-6-Chloro-2-(furan-2-ylmethylidene)-2,3,4,9-tetrahydro-1H-carbazol-1-one
by: R. J. Butcher, et al.
Published: (2010-12-01)

Crystal structure of (E)-2-(furan-2-ylmethylidene)-2,3,4,9-tetrahydro-1H-carbazol-1-one
by: A. Thiruvalluvar, et al.
Published: (2018-01-01)

P593: MULTIDIMENSIONAL ANALYSIS OF THE B CELL RECEPTOR OFFERS INSIGHT INTO THE ONTOGENETIC RELATIONSHIP OF MONOCLONAL B-CELL LYMPHOCYTOSIS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
by: A. Agathangelidis, et al.
Published: (2022-06-01)

(E)-2-[(Furan-2-yl)methylidene]-7-methyl-2,3,4,9-tetrahydro-1H-carbazol-1-one
by: A. Thiruvalluvar, et al.
Published: (2013-02-01)

2-[2-(Methylamino)benzoyl]-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-one
by: Lin Li, et al.
Published: (2010-06-01)

PB2349: A PHASE 1, OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY OF SGR-1505 AS MONOTHERAPY IN SUBJECTS WITH MATURE B-CELL MALIGNANCIES
by: Adam Olszewski, et al.
Published: (2023-08-01)

9-(2-Hydroxy-6-oxocyclohex-1-en-1-yl)-2,3,4,9-tetrahydro-1H-xanthen-1-one
by: Shaaban K. Mohamed, et al.
Published: (2013-04-01)

Meteorological Data Warehousing and Analysis for Supporting Air Navigation
by: Georgia Garani, et al.
Published: (2022-10-01)

P836: LONG-TERM DYNAMICS OF CLONAL HEMATOPOIESIS IN CHRONIC IDIOPATHIC NEUTROPENIA (CIN)
by: G. Tsaknakis, et al.
Published: (2022-06-01)

Green Synthesis of 1-Aryl-2,3,4,9-Tetrahydro-1H-B-Carbolines using Fe(Iii)-Montmorillonite and Study of their Antimicrobial Activity
by: Gajjala Raghavendra Reddy,, et al.
Published: (2020)

Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications
by: Angelos Matheakakis, et al.
Published: (2021-09-01)

Diastereoselective synthesis of 1,1,4-trisubstituted-2,3,4,9-tetrahydrospiro-β-carbolines via glacial acetic acid catalyzed Pictet - Spengler reaction
by: Abdullah M. A. Shumaila, et al.
Published: (2010-12-01)

Participatory action research approaches and methods : connecting people, participation and place /
by: 266399 Kindon, Sara, et al.
Published: (2007)

Synthesis of All Stereoisomers of 1-(4-Methoxyphenyl)-2,3,4,9-tetrahydro-N-methyl-1H-pyrido[3,4-b]indole-3-carboxamide
by: Momoko Onda, et al.
Published: (2018-01-01)

What Are the Attributes Prioritized in the Choice of Therapy in Chronic Lymphocytic Leukemia? A Patient-physician Cross-matching Analysis of a Discrete Choice Experiment
by: Luca Laurenti, et al.
Published: (2022-09-01)

Participatory organization at work
by: Ronco, William C
Published: (2013)

Participatory public health
by: Manuj C. Weerasinghe
Published: (2006-12-01)

Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity
by: Electra Sofou, et al.
Published: (2022-12-01)

Indigenous Storytelling and Participatory Action Research
by: C. Susana Caxaj
Published: (2015-04-01)

P752: TRANSCRIPTOMIC ANALYSIS OF MYELOID-DERIVED SUPPRESSOR CELLS (MDSCS) IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA (CIN)
by: Nikoleta Bizymi, et al.
Published: (2023-08-01)

2,3,4,9-Tetrahydro-9-(3-hydroxy-1,4-dioxo-1H-dihydro-naphthalen-2-yl)-8-methoxy-3,3-dimethyl-1H-xanthen-1-one
by: Eito Yoshioka, et al.
Published: (2015-01-01)

P597: HIGH DOSE IRON IMPAIRS MALIGNANT B-CELL VIABILITY IN CHRONIC LYMPHOCYTIC LEUKEMIA
by: J. Bordini, et al.
Published: (2022-06-01)

Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Time to Retire?
by: Lydia Scarfò, et al.
Published: (2019-08-01)

BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia
by: Stefania Fiorcari, et al.
Published: (2020-08-01)